Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CERKL | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | MID1IP1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | TCOF1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | RAB3A | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | DNAJC4 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | AFF3 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | ACTR5 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | ZNF441 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | MAST2 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | NLK | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |